hexamethylene bisacetamide has been researched along with methylnitrosourea in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chun, HG; Cradock, J; Davignon, P; Grieshaber, C; Hoth, D; Leyland-Jones, B; Moon, R; Rifkind, R; Shoemaker, D; Wolpert-DeFilippes, M | 1 |
1 review(s) available for hexamethylene bisacetamide and methylnitrosourea
Article | Year |
---|---|
Hexamethylene bisacetamide: a polar-planar compound entering clinical trials as a differentiating agent.
Topics: Acetamides; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cell Line; Cyclophosphamide; Dogs; Drug Evaluation, Preclinical; Humans; Kinetics; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid; Mammary Neoplasms, Experimental; Methylnitrosourea; Mice; Neoplasms; Rats; Tumor Stem Cell Assay | 1986 |